Malignant germ cell tumor of the corpus uteri

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:213751C54.0C54.1C54.2
Who is this for?
Show terms as
6Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Malignant germ cell tumor of the corpus uteri is an extremely rare neoplasm arising from germ cells located within the body (corpus) of the uterus. Germ cell tumors typically originate from primordial germ cells and are more commonly found in the ovaries or testes, but in rare instances they can develop in extragonadal sites including the uterine corpus. These tumors may include histological subtypes such as yolk sac tumor (endodermal sinus tumor), choriocarcinoma (non-gestational type), immature teratoma, embryonal carcinoma, or mixed germ cell tumors occurring within the uterine body. The ICD-10 codes C54.0 through C54.8 correspond to malignant neoplasms of different regions of the corpus uteri, including the isthmus, endometrium, myometrium, fundus, and overlapping sites. Patients may present with abnormal uterine bleeding, pelvic pain, an enlarging uterine mass, or symptoms related to advanced disease such as abdominal distension. Elevated serum tumor markers including alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (β-hCG), and lactate dehydrogenase (LDH) may be observed depending on the histological subtype and can aid in diagnosis and monitoring. Due to the rarity of this condition, diagnosis often requires careful histopathological examination and immunohistochemical staining to distinguish it from more common uterine malignancies such as endometrial carcinoma or gestational trophoblastic disease. Treatment approaches are largely extrapolated from experience with ovarian germ cell tumors and typically involve surgical management, often including hysterectomy, combined with platinum-based chemotherapy regimens such as BEP (bleomycin, etoposide, and cisplatin). Prognosis varies depending on the specific histological subtype, stage at diagnosis, and response to chemotherapy. Given the extreme rarity of this tumor, management is best guided by multidisciplinary teams at specialized centers, and patients may benefit from referral to clinical trials when available.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Malignant germ cell tumor of the corpus uteri.

View clinical trials →

No actively recruiting trials found for Malignant germ cell tumor of the corpus uteri at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Malignant germ cell tumor of the corpus uteri community →

Specialists

6 foundView all specialists →
LN
Lakshmi Nayak
BOSTON, MA
Specialist
PI on 1 active trial3 Malignant germ cell tumor of the corpus uteri publications
MG
Mrinal Gounder
NEW YORK, NY
Specialist
PI on 1 active trial2 Malignant germ cell tumor of the corpus uteri publications
KF
Keith T Flaherty
Birmingham, Alabama
Specialist

Rare Disease Specialist

PI on 1 active trial2 Malignant germ cell tumor of the corpus uteri publications
MC
Michael Cibull
LEXINGTON, KY
Specialist
PI on 1 active trial3 Malignant germ cell tumor of the corpus uteri publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Malignant germ cell tumor of the corpus uteri.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Malignant germ cell tumor of the corpus uteriForum →

No community posts yet. Be the first to share your experience with Malignant germ cell tumor of the corpus uteri.

Start the conversation →

Latest news about Malignant germ cell tumor of the corpus uteri

No recent news articles for Malignant germ cell tumor of the corpus uteri.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Malignant germ cell tumor of the corpus uteri

What is Malignant germ cell tumor of the corpus uteri?

Malignant germ cell tumor of the corpus uteri is an extremely rare neoplasm arising from germ cells located within the body (corpus) of the uterus. Germ cell tumors typically originate from primordial germ cells and are more commonly found in the ovaries or testes, but in rare instances they can develop in extragonadal sites including the uterine corpus. These tumors may include histological subtypes such as yolk sac tumor (endodermal sinus tumor), choriocarcinoma (non-gestational type), immature teratoma, embryonal carcinoma, or mixed germ cell tumors occurring within the uterine body. The IC

How is Malignant germ cell tumor of the corpus uteri inherited?

Malignant germ cell tumor of the corpus uteri follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Malignant germ cell tumor of the corpus uteri?

6 specialists and care centers treating Malignant germ cell tumor of the corpus uteri are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.